- Home
- About
- PsychU For You
- Topics
- Mental Health Disorders
- Agitation
- Bipolar Disorder
- Depression
- Pseudobulbar Affect (PBA)
- PTSD/Trauma
- Schizophrenia
- Substance Use Disorders
- Topics of Interest
- Care Coordination
- Digital Health
- Diversity, Equity, & Inclusion
- Health Care Policy, Quality & Payer Administration
- Long-Term Care
- Stigma
- Suicide Awareness
- Wellness
- Events
- Content
- Supporting Organizations
Agitation Associated With Alzheimer’s Dementia (AAD) In The Long-Term Care (LTC) Setting: An Introduction To The Agitation In Alzheimer’s Screener For Caregivers (AASCTM)

Thank You For Attending Today’s Webinar
Please tell us what you thought about today’s presentation by taking the survey below:
About This Event
Agitation Associated With Alzheimer’s Dementia (AAD) In The Long-Term Care (LTC) Setting: An Introduction To The Agitation In Alzheimer’s Screener For Caregivers (AASCTM)
This webinar will describe how agitation associated with Alzheimer’s dementia (AAD) can manifest within the long-term care (LTC) setting and the burden that AAD can pose to both residents and caregivers. Presenters will discuss current approaches to recognizing and documenting AAD in the LTC setting, as well as potential challenges faced by nursing home caregivers. The Agitation in Alzheimer’s Screener for Caregivers (AASCTM) will be introduced as a potential tool for the identification and documentation of agitation in LTC residents with Alzheimer’s dementia.

Manju Beier, PharmD, BCGP, FASCP
President & Founder, Geriatric Consultant Resources, LLC; Adjunct Associate Professor of Pharmacy at the University of Michigan
More

Jennifer Simmoneau, PhD (OPDC)
Senior Long-Term Care Medical Science Liaison, Medical Affairs
Speaker Manju Beier is a paid consultant of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC)
Speaker Jennifer Simmoneau, PhD is a paid consultant of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC)